EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
164 hedge funds and large institutions have $633M invested in Eagle Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 55 increasing their positions, 68 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
19% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 68
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
164
Holding in Top 10
–
Calls
$983K
Puts
$388K
Top Buyers
| 1 | +$13.5M | |
| 2 | +$9.02M | |
| 3 | +$7.4M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$7.29M |
| 5 |
Millennium Management
New York
|
+$5.09M |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$9.88M | |
| 3 | -$7.28M | |
| 4 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$6.88M |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$5.76M |